Active-ingredient Dossier
Posaconazole
Active-ingredient Dossier for Posaconazole (triazole antifungal). Australian brands, products, PBS listings, PBAC outcomes — compiled by arcimedes.
- Brand: POSACONAZOLE
- Brand: NOXAFIL
- Brand: AXOFIL
- Brand: POSACONAZOLE
- Brand: POSACONAZOLE
- Brand: POSACONAZOLE JUNO
- Therapeutic area: Infectious Disease
What is
Posaconazole Posaconazole is a triazole antifungal.
Australian brands containing
Posaconazole — POSACONAZOLE — NOXAFIL — AXOFIL — POSACONAZOLE JUNO — POSACONAZOLE-WGR — POSMED — APX-POSACONAZOLE — POSACONAZOLE-DRLA
Therapeutic areas
Posaconazole is registered in haematology (12 brands) and infectious disease (1 brand).
Sponsor landscape
Posaconazole is marketed by seven sponsors: Medsurge Pharma, Arrotex Pharmaceuticals, Dr Reddy's Laboratories, Juno Pharmaceuticals, Pharmacor, and Merck Sharp & Dohme.
PBS and regulatory activity
One brand containing posaconazole is PBS-listed, with the latest PBS schedule date of 1 May 2026. The latest PBAC outcome was recorded on 1 July 2018.